Please wait while the formulary information is being retrieved.
DENAVIR (PENCICLOVIR)
- Herpes labialis
1 % topical cream
- Apply to the affected area(s) by topical route every 2 hours during waking hours for 4 days
Herpes labialis
- Apply to the affected area(s) by topical route every 2 hours during waking hours for 4 days
- Apply to the affected area(s) by topical route every 2 hours during waking hours
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- No disease contraindications
DENAVIR (PENCICLOVIR)
- Herpes labialis
- None
- Headache disorder
More Frequent
Severe
Less Severe
- None
- Dysgeusia
- Erythema
- Hypesthesia
- Skin rash
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Penciclovir
Safety and efficacy not established age < 12 years.
- 1 Day – 12 Years
- Safety and efficacy not established age < 12 years.
Penciclovir
- Severity Level:
2
- Additional Notes: Systemic absorption not likely after topical administration.
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
Penciclovir
No systemic absorption with topical use, infant exposure not expected.
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | No systemic absorption with topical use, infant exposure not expected. |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Herpes labialis | |
| B00.1 | Herpesviral vesicular dermatitis |
| 0-9 | A-Z |
|---|---|
| B00.1 | Herpesviral vesicular dermatitis |
Formulary Reference Tool